Counterfeit Version of Sun Pharma anti-epileptic medicine Levipil 500 seized in Telangana

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2025-07-08 07:00 GMT   |   Update On 2025-07-08 07:00 GMT
Advertisement

Telangana: Drugs Control Administration, Telangana, seized Spurious Drug 'Levipil 500' Tablets (Levetiracetam Tablets 500 mg), falsely claimed to be manufactured by Sun Pharma Laboratories Ltd.

Based on intelligence gathered by Drugs Control Administration officials, raids were conducted at several dealers in Hyderabad and Karimnagar, leading to the detection of a Spurious Drug – a Counterfeit Version of ‘Levipil 500’ Tablets (Levetiracetam Tablets 500 mg) – circulating in the market.

Levipil 500 Tablet is an anti-epileptic medicine used to treat fits in epilepsy.

Counterfeit drugs were seized during the raids at Arvind Pharma Distributors, located in SBI Colony, Kavadiguda, Hyderabad, and at Venu Medical Agencies, located in Sai Nagar, Doctors Street, Karimnagar.

A comparison statement for the suspected batches was obtained from the original manufacturer, Sun Pharma Laboratories Ltd., against the corresponding genuine batch. The manufacturer confirmed that the batch of ‘Levipil 500’ Tablets (Levetiracetam Tablets 500 mg) detected by the Drugs Control Administration were indeed “Counterfeit Drugs”. 

"During the raid conducted on 4 th July, 2025 at Arvind Pharma Distributors, SBI Colony, Kavadiguda, Hyderabad, and the raid conducted on 5 th July, 2025 at Venu Medical Agencies, located in Sai Nagar, Doctors Street, Karimnagar, a counterfeit version of ‘Levipil 500’ Tablets (Levetiracetam Tablets 500 mg), bearing Batch No.: GTF1540A, Mfg. Date: May-2024, Exp. Date: Apr-2026, and falsely claimed to be manufactured by Sun Pharma Laboratories Ltd., Vill. Kokjhar, Dist. Kamrup, Assam, was detected," the Telangana Drugs Control Administration said in a press note.

Counterfeit drugs were seized during both raids.

Sri G. Sreenivas, Deputy Director-I, Sri. M. Srinivasulu, Assistant Director, Karimnagar, Smt. D. Saritha, Assistant Director, Secunderabad, Smt. P. Renuka, Drugs Inspector, Musheerabad, Sri. P. Karthik Bharadwaj, Drugs Inspector, Karimnagar, Sri. B. Govind Singh, Drugs Inspector, Begumpet, Sri. C. Vivekananda Reddy, Drugs Inspector, Khairatabad, Sri V. Ajay, Drugs Inspector, Goshamahal, Sri. G. Anil, Drugs Inspector, Malakpet, Sri. K. Murali Krishna, Drugs Inspector, Malkajgiri, Sri Raja Reddy, Drugs Inspector, Kamareddy, Smt. Page 3 of 5 T. Chandana, Drugs Inspector, Mancherial, and Sri. P. Shravan Kumar, Drugs Inspector, Peddapalli, were among the officers who carried out the raids and detected the counterfeit drug stocks.

Further investigation will be conducted, and appropriate action will be taken against all offenders involved.

Spurious drugs pose a significant threat to public health, endangering patients' well-being. These drugs not only fail to treat the intended disease but also can lead to severe health complications over time. 
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News